Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Oct 5:36:101218.
doi: 10.1016/j.conctc.2023.101218. eCollection 2023 Dec.

Monitoring and responding to signals of suicidal ideation in pragmatic clinical trials: Lessons from the GRACE trial for Chronic Sickle Cell Disease Pain

Eric S Swirsky  1 , Andrew D Boyd  1 , Carol Gu  1 , Larisa A Burke  1 , Ardith Z Doorenbos  1 , Miriam O Ezenwa  2 , Mitchell R Knisely  3 , Jonathan W Leigh  1 , Hongjin Li  1 , Molly W Mandernach  2 , Robert E Molokie  1 , Crystal L Patil  1 , Alana D Steffen  1 , Nirmish Shah  3 , Victoria A deMartelly  1 , Karen L Staman  4 , Judith M Schlaeger  1
Affiliations

Monitoring and responding to signals of suicidal ideation in pragmatic clinical trials: Lessons from the GRACE trial for Chronic Sickle Cell Disease Pain

Eric S Swirsky et al. Contemp Clin Trials Commun. .

Abstract

Sickle cell disease (SCD) is a hemoglobin disorder and the most common genetic disorder that affects 100,000 Americans and millions worldwide. Adults living with SCD have pain so severe that it often requires opioids to keep it in control. Depression is a major global public health concern associated with an increased risk in chronic medical disorders, including in adults living with sickle cell disease (SCD). A strong relationship exists between suicidal ideation, suicide attempts, and depression. Researchers enrolling adults living with SCD in pragmatic clinical trials are obligated to design their methods to deliberately monitor and respond to symptoms related to depression and suicidal ideation. This will offer increased protection for their participants and help clinical investigators meet their fiduciary duties. This article presents a review of this sociotechnical milieu that highlights, analyzes, and offers recommendations to address ethical considerations in the development of protocols, procedures, and monitoring activities related to suicidality in depressed patients in a pragmatic clinical trial.

Keywords: Depression; Patient-reported outcomes; Pragmatic trial; Research ethics; Suicidal ideation; Suicidal monitoring.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Overview of socio-technical considerations for monitoring of suicidal ideation with the PHQ-9.
Fig. 2
Fig. 2
National Suicide Prevention Lifeline and Crisis Text Line. Deaf and hard of hearing research participants can use the number 1-800-799-4889.
Fig. 3
Fig. 3
Unintended consequences for new health information technology that remotely captures suicidal ideation symptoms.
Fig. 4
Fig. 4
Recommendations for monitoring and responding to suicidality in pragmatic clinical trials that measure depression as an outcome.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Data & Statistics on Sickle Cell Disease. CDC, Centers for Disease Control and Prevention; 2022. https://www.cdc.gov/ncbddd/sicklecell/data.html
    1. El Ariss A.B., Younes M., Matar J., Berjaoui Z. Prevalence of sickle cell trait in the southern suburbs of Beirut, Lebanon. Mediterr. J. Hematol. Infect. Dis. 2016;8 doi: 10.4084/mjhid.2016.015. - DOI - PMC - PubMed
    1. Major depression, national Institute of mental health (NIMH) https://www.nimh.nih.gov/health/statistics/major-depression n.d.
    1. Hiroeh U., Appleby L., Mortensen P.B., Dunn G. Death by homicide, suicide, and other unnatural causes in people with mental illness: a population-based study. Lancet. 2001;358:2110–2112. doi: 10.1016/S0140-6736(01)07216-6. - DOI - PubMed
    1. Hasan S.P., Hashmi S., Alhassen M., Lawson W., Castro O. Depression in sickle cell disease. J. Natl. Med. Assoc. 2003;95:533–537. - PMC - PubMed

LinkOut - more resources